Document:

Document

EXHIBIT 10.3

AMENDMENT TO THE
RESOLUTE FOREST PRODUCTS EQUITY INCENTIVE PLAN
EMPLOYEE NONQUALIFIED STOCK OPTION AGREEMENT
This Amendment to the Employee Nonqualified Stock Option Agreements (the “Agreements”) dated as of November 8, 2012 and November 6, 2013 granted under the Resolute Forest Products Equity Incentive Plan (previously named the AbitibiBowater Inc. 2010 Equity Incentive Plan), effective as of December 9, 2010, is made effective as of May 27, 2022 between Resolute Forest Products Inc., a Delaware corporation (the “Company”) and [Participant Name].  This Amendment is included in and made part of the respective Agreements.
1.         The last sentence of Section 4 of the Agreements is hereby amended and restated in its entirety to read as follows:
(b)        Notwithstanding the foregoing, if, on the last day on which the Option remains exercisable at the end of the 10 year term pursuant to the last sentence of Section 3 the Fair Market Value exceeds the Exercise Price, the Participant has not exercised the Option, and the Option has not expired, such Option shall be deemed to have been exercised by the Participant on such last day by means of a net exercise and the Company shall deliver to the Participant the number of shares of Stock for which the Option was deemed exercised less such number of shares of Stock required to be withheld to cover the payment of the Exercise Price and all applicable required withholding taxes, which portion of the Stock shall be delivered by the Company to its transfer agent who will sell them on behalf of the Participant in order to pay the exercise price and the withholding tax; provided that the foregoing shall also apply if the expiration of the 10 year term occurs during a blackout period and whether or not the Participant holds material nonpublic information on such date, notwithstanding provisions of the Company’s Insider Trading Policy as such deemed exercise will occur automatically and without an investment decision by the Participant; and provided further that no such sale of the net shares of Stock shall be permitted during a blackout period or while the Participant holds material nonpublic information.
2.         This Amendment has no effect on the other terms of the Agreements and the Agreements shall otherwise continue in effect.
IN WITNESS WHEREOF, the Company has caused this Amendment to be executed by a duly authorized officer on July 4, 2022.
RESOLUTE FOREST PRODUCTS INC.
By: __________________________________Document

EXHIBIT 10.4
1010, rue De La Gauchetière Ouest, bureau 400
Montréal, Québec, H3B 2N2    Canada
T 514-875-2160     resolutefp.com

June 23, 2022

*This is a translation from the signed agreement in French

Mr. Yves Laflamme
Re:  Agreement between Yves Laflamme and Resolute FP Canada Inc.
Yves,
I am pleased to confirm the renewal of your appointment as Special Advisor to the President and Chief Executive Officer. The terms and conditions of the agreements dated April 9, 2021, and March 30, 2022, remain unchanged, except for the salary, the term and termination, which are amended as follows:
Date of Appointment & Term
This agreement becomes effective on July 1, 2022.
Annual Base Salary
As of your date of appointment, your base salary will be at a annual rate of $100,000 in nominal value, less applicable deductions, payable in semi-monthly installments. The semi-monthly installments will be deposited directly into your personal bank account. Your annual salary includes your representation of Resolute at the board of directors of Serres Toundra and your involvement in certain mandates in relation to this agreement.
Your base salary will be subject to the Company’s currency policy for executives. For 2022, 63.5% of your base salary will be denominated in Canadian dollars and 36.5% will be denominated in US dollars, up and until the Company modifies this ratio.
Termination
The term of your employment will be for twelve months from the effective date, terminating on June 30, 2023. Either party may, at any time and for cause, terminate unilaterally the present agreement without prior notice.
If you have any questions concerning this offer, please let me know.
Best regards,
			
	/s/ Remi G. Lalonde
	Remi G. Lalonde
	President and Chief Executive Officer

I have read the herein letter and hereby accept these terms and conditions.
									
	/s/ Yves Laflamme		July 28, 2022
	Yves Laflamme		DateDocument

Exhibit 10.2
Lyell Immunopharma, Inc.
Notice and Acceptance of Amendment to Stock Options 
(Extension of Options Exercise Period)
August 4, 2022
Elizabeth Homans

Dear Liz,
I am pleased to inform you that the Compensation Committee of the Board of Directors of Lyell Immunopharma, Inc. (the “Company”) approved an amendment to the stock options granted to you under the Company’s 2018 Equity Incentive Plan and 2021 Equity Incentive Plan (each, a “Plan” and together the “Plans”) listed on Attachment 1 hereto (each, an “Option” and together, the “Options”) to provide for the Extended Exercise Window (as defined below) for any vested and exercisable Options as of the date of your termination of employment, subject to the terms and conditions below.  

If, no later than 11:59 p.m. Eastern Time on September 1, 2022 (the “Deadline”), you accept the offer set forth in this Notice to amend the Options, then upon your termination of employment with the Company, the period during which you may exercise such Options to the extent outstanding, unexercised and vested as of your termination of employment will be the Extended Exercise Window, subject to your satisfaction of the release condition (the “Release Condition”) for the receipt of severance benefits set forth in Section 3(b) of your amended offer of employment with the Company dated July 24, 2020 (the “Amended Offer Letter) and the terms of the Options set forth in the Amended Offer Letter or the agreements related thereto shall remain in full force and effect, except as specifically amended hereby.  

“Extended Exercise Window” means, in the event of the termination of your employment with the Company, the period during which you may exercise the Options (to the extent vested and exercisable (under the terms of your Amended Offer Letter) as of the date of such termination) will be the earlier of (i) one hundred eighty (180) days following the date after the date of your termination in which you receive notice from the Company that it reasonably believes you are no longer in possession of material non-public information relating to the Company, and (ii) the Expiration Date (as defined in the Notice of Stock Option Grant covering the applicable Option), provided that the applicable Option may terminate earlier pursuant to the applicable Plan, including without limitation in connection with a dissolution or liquidation of the Company or certain corporate transactions as described in the applicable Plan.    
By signing below, you acknowledge and agree to the following potential tax consequences of this amendment to your Options that are ISOs (if any). For each of your Options that is an ISO with a per share exercise price below the per share fair market value of the Company’s common stock on the effective date of this amendment (an “In-the-Money ISO”), this amendment will be a modification of such Option for federal tax purposes and will be treated as the grant of a new option under the applicable federal tax rules, causing the Option to no longer qualify as an ISO.  As a result, following the effectiveness of this amendment, such Option will be treated as an NSO for federal tax purposes.  However, if such Option is an ISO but is not an In-the-Money ISO, such Option will remain an ISO and your applicable holding period for purposes of determining the occurrence of a disqualifying disposition of the ISO (i.e., 2 years from the date of grant) will be restarted as of the effective date of this amendment.   If any of your ISOs are converted to NSOs as a result of this amendment, you must satisfy all applicable tax withholding obligations upon exercise of such Options.  You should consult with your tax advisor regarding the implications of your agreement to amend the Options that are ISOs to provide for the Extended Exercise Window.  
If you wish to accept the amendment of the Options (to the extent outstanding and unexercised as of the acceptance date) to provide for the Extended Exercise Window, please sign below where indicated and return your signed acceptance to Catherine Friedman no later than the Deadline.  If we receive your signed acceptance on or before the Deadline, then the Extended Exercise Window will be effective immediately with respect to your Options on the date we receive such acceptance (to the extent such Options are outstanding and unexercised as of such date), subject to the Release Condition.  If we do not receive your signed acceptance by the 
			
	271290148 v8

Deadline, then the Options will not be amended and will remain subject to the applicable standard period for exercising the Options as set forth in the applicable stock option agreement.
Except as expressly provided herein, the Options shall continue to be governed by the applicable Notices of Stock Option Grant, Stock Option Agreements, the applicable Plan and the vesting acceleration provision set forth in Section 6(d) of the Amended Offer Letter.  You will not receive agreements reflecting the Extended Exercise Window.  You should retain a copy of this letter with your original Notices of Stock Option Grant and Stock Option Agreements.   
Please contact David Peinsipp, Cooley LLP, if you have any questions.
Sincerely,
/s/ Catherine Friedman
______________________________________
Catherine Friedman, Director

Acknowledged and Agreed:

/s/ Elizabeth Homans                August 4, 2022                
Elizabeth Homans                    Date

			
	

Attachment 1

Options

												
	Grant Date	Total Number of Shares Subject to Option at Grant	Type of Option	Per Share Exercise Price
	November 6, 2018	1,000,000	NSO	$0.10
	November 6, 2018	2,469,198	NSO	$0.10
	November 6, 2018	693,840	NSO	$0.10
	January 16, 2020	119,171	NSO	$3.65
	January 16, 2020	110,829	NSO	$3.65
	July 15, 2020	11,191	NSO	$5.81
	July 15, 2020	3,341,109	NSO	$5.81
	February 12, 2021	16,025	NSO	$6.24
	February 12, 2021	567,507	NSO	$6.24
	September 13, 2021	31,150	NSO	$16.05
	September 13, 2021	552,382	NSO	$16.05
	September 13, 2021	786,937	NSO	$16.05
	March 16, 2022	83,610	ISO	$5.98
	March 16, 2022	1,395,890	NSO	$5.98

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00347-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00347-of-00352.parquet"}], [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00347-of-00352.parquet"}]]